{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T02:06:53Z","timestamp":1779156413690,"version":"3.51.4"},"reference-count":34,"publisher":"Journal of Biomedical Research","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Biomed Res"],"published-print":{"date-parts":[[2026]]},"DOI":"10.7555\/jbr.40.20260064","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T01:21:31Z","timestamp":1779153691000},"page":"1","source":"Crossref","is-referenced-by-count":0,"title":["&lt;i&gt;Lactobacillus murinus&lt;\/i&gt; improves liver fibrosis in primary sclerosing cholangitis mice by decreasing taurocholic acid and regulating M2 macrophage polarization"],"prefix":"10.7555","volume":"40","author":[{"given":"Chenchen","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zixuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dilixiati","family":"Kadier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zejia","family":"Hao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4380","reference":[{"key":"10.7555\/JBR.40.20260064.swyxyjzzywb.1","doi-asserted-by":"publisher","unstructured":"Trivedi PJ, Hirschfield GM. Recent advances in clinical practice: Epidemiology of autoimmune liver diseases[J]. <i>Gut<\/i>, 2021, 70(10): 1989\u20132003.","DOI":"10.1136\/gutjnl-2020-322362"},{"key":"10.7555\/JBR.40.20260064.swyxyjzzywb.2","doi-asserted-by":"publisher","unstructured":"\u00d6zdirik B, Schnabl B. Microbial players in primary sclerosing cholangitis: Current evidence and concepts[J]. <i>Cell Mol Gastroenterol Hepatol<\/i>, 2024, 17(3): 423\u2013438.","DOI":"10.1016\/j.jcmgh.2023.12.005"},{"key":"10.7555\/JBR.40.20260064.swyxyjzzywb.3","doi-asserted-by":"publisher","unstructured":"Xie G, Jiang R, Wang X, et al. Conjugated secondary 12\u03b1-hydroxylated bile acids promote liver fibrogenesis[J]. <i>eBioMedicine<\/i>, 2021, 66: 103290.","DOI":"10.1016\/j.ebiom.2021.103290"},{"key":"10.7555\/JBR.40.20260064.swyxyjzzywb.4","doi-asserted-by":"publisher","unstructured":"Fuchs CD, Trauner M. Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology[J]. <i>Nat Rev Gastroenterol Hepatol<\/i>, 2022, 19(7): 432\u2013450.","DOI":"10.1038\/s41575-021-00566-7"},{"key":"10.7555\/JBR.40.20260064.swyxyjzzywb.5","doi-asserted-by":"publisher","unstructured":"Zhao Q, Dai M, Huang R, et al. <i>Parabacteroides distasonis<\/i> ameliorates hepatic fibrosis potentially via modulating intestinal bile acid metabolism and hepatocyte pyroptosis in male mice[J]. <i>Nat Commun<\/i>, 2023, 14(1): 1829.","DOI":"10.1038\/s41467-023-37459-z"},{"key":"10.7555\/JBR.40.20260064.swyxyjzzywb.6","doi-asserted-by":"publisher","unstructured":"Liu Y, Chen K, Li F, et al. Probiotic <i>Lactobacillus rhamnosus<\/i> GG prevents liver fibrosis through inhibiting hepatic bile acid synthesis and enhancing bile acid excretion in mice[J]. <i>Hepatology<\/i>, 2020, 71(6): 2050\u20132066.","DOI":"10.1002\/hep.30975"},{"key":"10.7555\/JBR.40.20260064.swyxyjzzywb.7","doi-asserted-by":"publisher","unstructured":"Jiang B, Yuan G, Wu J, et al. <i>Prevotella copri<\/i> ameliorates cholestasis and liver fibrosis in primary sclerosing cholangitis by enhancing the FXR signalling pathway[J]. <i>Biochim Biophys Acta Mol Basis Dis<\/i>, 2022, 1868(3): 166320.","DOI":"10.1016\/j.bbadis.2021.166320"},{"key":"10.7555\/JBR.40.20260064.swyxyjzzywb.8","doi-asserted-by":"publisher","unstructured":"Shen Y, Jiang B, Zhang C, et al. Combined inhibition of the TGF-\u03b21\/Smad pathway by <i>Prevotella copri<\/i> and <i>Lactobacillus murinus<\/i> to reduce inflammation and fibrosis in primary sclerosing cholangitis[J]. <i>Int J Mol Sci<\/i>, 2023, 24(13): 11010.","DOI":"10.3390\/ijms241311010"},{"key":"10.7555\/JBR.40.20260064.swyxyjzzywb.9","doi-asserted-by":"publisher","unstructured":"Fan H, Sheng S, Li D, et al. Heat-killed <i>Lactobacillus murinus<\/i> confers neuroprotection against dopamine neuronal loss by targeting NLRP3 inflammasome[J]. <i>Bioeng Transl Med<\/i>, 2023, 8(2): e10455.","DOI":"10.1002\/btm2.10455"},{"key":"10.7555\/JBR.40.20260064.swyxyjzzywb.10","doi-asserted-by":"publisher","unstructured":"Tang C, Kamiya T, Liu Y, et al. Inhibition of dectin-1 signaling ameliorates colitis by inducing <i>Lactobacillus<\/i>-mediated regulatory T cell expansion in the intestine[J]. <i>Cell Host Microbe<\/i>, 2015, 18(2): 183\u2013197.","DOI":"10.1016\/j.chom.2015.07.003"},{"key":"10.7555\/JBR.40.20260064.swyxyjzzywb.11","doi-asserted-by":"publisher","unstructured":"Hu J, Deng F, Zhao B, et al. <i>Lactobacillus murinus<\/i> alleviate intestinal ischemia\/reperfusion injury through promoting the release of interleukin-10 from M2 macrophages via Toll-like receptor 2 signaling[J]. <i>Microbiome<\/i>, 2022, 10(1): 38.","DOI":"10.1186\/s40168-022-01227-w"},{"key":"10.7555\/JBR.40.20260064.swyxyjzzywb.12","doi-asserted-by":"publisher","unstructured":"Foley MH, Walker ME, Stewart AK, et al. Bile salt hydrolases shape the bile acid landscape and restrict <i>Clostridioides difficile<\/i> growth in the murine gut[J]. <i>Nat Microbiol<\/i>, 2023, 8(4): 611\u2013628.","DOI":"10.1038\/s41564-023-01337-7"},{"key":"10.7555\/JBR.40.20260064.swyxyjzzywb.13","doi-asserted-by":"publisher","unstructured":"Guicciardi ME, Trussoni CE, Krishnan A, et al. Macrophages contribute to the pathogenesis of sclerosing cholangitis in mice[J]. <i>J Hepatol<\/i>, 2018, 69(3): 676\u2013686.","DOI":"10.1016\/j.jhep.2018.05.018"},{"key":"10.7555\/JBR.40.20260064.swyxyjzzywb.14","doi-asserted-by":"publisher","unstructured":"Atri C, Guerfali FZ, Laouini D. Role of human macrophage polarization in inflammation during infectious diseases[J]. <i>Int J Mol Sci<\/i>, 2018, 19(6): 1801.","DOI":"10.3390\/ijms19061801"},{"key":"10.7555\/JBR.40.20260064.swyxyjzzywb.15","doi-asserted-by":"publisher","unstructured":"Li Q, Cheng Y, Zhang Z, et al. Inhibition of ROCK ameliorates pulmonary fibrosis by suppressing M2 macrophage polarisation through phosphorylation of STAT3[J]. <i>Clin Transl Med<\/i>, 2022, 12(10): e1036.","DOI":"10.1002\/ctm2.1036"},{"key":"10.7555\/JBR.40.20260064.swyxyjzzywb.16","doi-asserted-by":"publisher","unstructured":"Luo L, Wang S, Hu Y, et al. Precisely regulating M2 subtype macrophages for renal fibrosis resolution[J]. <i>ACS Nano<\/i>, 2023, 17(22): 22508\u201322526.","DOI":"10.1021\/acsnano.3c05998"},{"key":"10.7555\/JBR.40.20260064.swyxyjzzywb.17","doi-asserted-by":"publisher","unstructured":"Wang Y, Zhang Y, Li J, et al. Hypoxia induces M2 macrophages to express VSIG4 and mediate cardiac fibrosis after myocardial infarction[J]. <i>Theranostics<\/i>, 2023, 13(7): 2192\u20132209.","DOI":"10.7150\/thno.78736"},{"key":"10.7555\/JBR.40.20260064.swyxyjzzywb.18","doi-asserted-by":"publisher","unstructured":"DeNardo DG, Barreto JB, Andreu P, et al. CD<sup>4+<\/sup> T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages[J]. <i>Cancer Cell<\/i>, 2009, 16(2): 91\u2013102.","DOI":"10.1016\/j.ccr.2009.06.018"},{"key":"10.7555\/JBR.40.20260064.swyxyjzzywb.19","doi-asserted-by":"publisher","unstructured":"Foley MH, O\u2019Flaherty S, Allen G, et al. <i>Lactobacillus<\/i> bile salt hydrolase substrate specificity governs bacterial fitness and host colonization[J]. <i>Proc Natl Acad Sci U S A<\/i>, 2021, 118(6): e2017709118.","DOI":"10.1073\/pnas.2017709118"},{"key":"10.7555\/JBR.40.20260064.swyxyjzzywb.20","doi-asserted-by":"publisher","unstructured":"Song Z, Cai Y, Lao X, et al. Taxonomic profiling and populational patterns of bacterial bile salt hydrolase (BSH) genes based on worldwide human gut microbiome[J]. <i>Microbiome<\/i>, 2019, 7(1): 9.","DOI":"10.1186\/s40168-019-0628-3"},{"key":"10.7555\/JBR.40.20260064.swyxyjzzywb.21","doi-asserted-by":"publisher","unstructured":"Brandl K, Hartmann P, Jih LJ, et al. Dysregulation of serum bile acids and FGF19 in alcoholic hepatitis[J]. <i>J Hepatol<\/i>, 2018, 69(2): 396\u2013405.","DOI":"10.1016\/j.jhep.2018.03.031"},{"key":"10.7555\/JBR.40.20260064.swyxyjzzywb.22","doi-asserted-by":"publisher","unstructured":"Mackowiak B, Fu Y, Maccioni L, et al. Alcohol-associated liver disease[J]. <i>J Clin Invest<\/i>, 2024, 134(3): e176345.","DOI":"10.1172\/JCI176345"},{"key":"10.7555\/JBR.40.20260064.swyxyjzzywb.23","doi-asserted-by":"publisher","unstructured":"Jung K, Kim M, So J, et al. Farnesoid X receptor activation impairs liver progenitor cell-mediated liver regeneration via the PTEN-PI3K-AKT-mTOR axis in zebrafish[J]. <i>Hepatology<\/i>, 2021, 74(1): 397\u2013410.","DOI":"10.1002\/hep.31679"},{"key":"10.7555\/JBR.40.20260064.swyxyjzzywb.24","doi-asserted-by":"publisher","unstructured":"Zhang Z, Shang J, Yang Q, et al. Exosomes derived from human adipose mesenchymal stem cells ameliorate hepatic fibrosis by inhibiting PI3K\/Akt\/mTOR pathway and remodeling choline metabolism[J]. <i>J Nanobiotechnology<\/i>, 2023, 21(1): 29.","DOI":"10.1186\/s12951-023-01788-4"},{"key":"10.7555\/JBR.40.20260064.swyxyjzzywb.25","doi-asserted-by":"publisher","unstructured":"Liu B, Wang J, Wang G, et al. Hepatocyte-derived exosomes deliver H2AFJ to hepatic stellate cells and promote liver fibrosis <i>via<\/i> the MAPK\/STMN1 axis activation[J]. <i>Int Immunopharmacol<\/i>, 2023, 115: 109605.","DOI":"10.1016\/j.intimp.2022.109605"},{"key":"10.7555\/JBR.40.20260064.swyxyjzzywb.26","doi-asserted-by":"crossref","unstructured":"Frangogiannis N. Transforming growth factor-\u03b2 in tissue fibrosis[J]. <i>J Exp Med<\/i>, 2020, 217(3): e20190103.","DOI":"10.1084\/jem.20190103"},{"key":"10.7555\/JBR.40.20260064.swyxyjzzywb.27","doi-asserted-by":"publisher","unstructured":"Pan F, Zhang L, Li M, et al. Predominant gut <i>Lactobacillus murinus<\/i> strain mediates anti-inflammaging effects in calorie-restricted mice[J]. <i>Microbiome<\/i>, 2018, 6(1): 54.","DOI":"10.1186\/s40168-018-0440-5"},{"key":"10.7555\/JBR.40.20260064.swyxyjzzywb.28","doi-asserted-by":"publisher","unstructured":"Long J, Shi Z, Miao Z, et al. <i>Lactobacillus murinus<\/i> alleviates insulin resistance via promoting L-citrulline synthesis[J]. <i>J Endocrinol Invest<\/i>, 2025, 48(4): 1005\u20131015.","DOI":"10.1007\/s40618-024-02500-5"},{"key":"10.7555\/JBR.40.20260064.swyxyjzzywb.29","doi-asserted-by":"publisher","unstructured":"Hu Y, Ding X, Liu H, et al. Effects of <i>Lactobacillus paracasei<\/i> N1115 on gut microbial imbalance and liver function in patients with hepatitis B-related cirrhosis[J]. <i>World J Gastroenterol<\/i>, 2024, 30(11): 1556\u20131571.","DOI":"10.3748\/wjg.v30.i11.1556"},{"key":"10.7555\/JBR.40.20260064.swyxyjzzywb.30","doi-asserted-by":"publisher","unstructured":"Wu L, Zhou J, Zhou A, et al. <i>Lactobacillus acidophilus<\/i> ameliorates cholestatic liver injury through inhibiting bile acid synthesis and promoting bile acid excretion[J]. <i>Gut Microbes<\/i>, 2024, 16(1): 2390176.","DOI":"10.1080\/19490976.2024.2390176"},{"key":"10.7555\/JBR.40.20260064.swyxyjzzywb.31","doi-asserted-by":"publisher","unstructured":"Hsu CL, Schnabl B. The gut-liver axis and gut microbiota in health and liver disease[J]. <i>Nat Rev Microbiol<\/i>, 2023, 21(11): 719\u2013733.","DOI":"10.1038\/s41579-023-00904-3"},{"key":"10.7555\/JBR.40.20260064.swyxyjzzywb.32","doi-asserted-by":"publisher","unstructured":"Chen M, Wang Y, Chen L, et al. Epiberberine ameliorates ulcerative colitis by regulating bile acids hepatoenteral circulation through intestinal FXR[J]. <i>Phytomedicine<\/i>, 2025, 143: 156831.","DOI":"10.1016\/j.phymed.2025.156831"},{"key":"10.7555\/JBR.40.20260064.swyxyjzzywb.33","doi-asserted-by":"publisher","unstructured":"Nevens F, Trauner M, Manns MP. Primary biliary cholangitis as a roadmap for the development of novel treatments for cholestatic liver diseases[J]. <i>J Hepatol<\/i>, 2023, 78(2): 430\u2013441.","DOI":"10.1016\/j.jhep.2022.10.007"},{"key":"10.7555\/JBR.40.20260064.swyxyjzzywb.34","doi-asserted-by":"publisher","unstructured":"Jiang M, Li F, Liu Y, et al. Probiotic-derived nanoparticles inhibit ALD through intestinal miR194 suppression and subsequent FXR activation[J]. <i>Hepatology<\/i>, 2023, 77(4): 1164\u20131180.","DOI":"10.1002\/hep.32608"}],"container-title":["Journal of Biomedical Research"],"original-title":[],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T01:21:33Z","timestamp":1779153693000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jbr-pub.org.cn\/article\/doi\/10.7555\/JBR.40.20260064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":34,"alternative-id":["JBR-2026-0064"],"URL":"https:\/\/doi.org\/10.7555\/jbr.40.20260064","relation":{},"ISSN":["1674-8301","1674-8301"],"issn-type":[{"value":"1674-8301","type":"print"},{"value":"1674-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]}}}